Success Stories: With Premium Processing Upgrade and Our Dedicated Team, an Indian Staff Research Associate III in Medicinal Chemistry Achieves EB1A Approval Within 5 Months
Client’s Testimonial:
“That was really great news!!! for me. Thank you for letting me know and did a great job throughout my EB1A petition.”
On January 24th, 2023, we received another EB-1A (Alien of Extraordinary Ability) approval for a Staff Research Associate III in the Field of Medicinal Chemistry (Approval Notice).
General Field: Medicinal Chemistry
Position at the Time of Case Filing: Staff Research Associate III
Country of Origin: India
Approval Notice Date: January 24th, 2023
Processing Time: 4 months, 25 days (Premium Processing Requested)
Case Summary:
One of the few leading synthetic organic chemistry experts in medicinal chemistry; our client hired North America Immigration Law Group to extend our help in achieving EB1A approval on his behalf. The EB1A (Alien of Extraordinary Ability) category of nonimmigrant visa is for those non-Americans who have a proven track record of excellence in their area of research. This can be proved by national and international recognition or awards as well as funding received from well-known institutions. So, we started evaluating his mailed credentials before preparing a petition packet for him and noted that he is especially known for developing synthetic routes for drug compounds with practical applications in treating complex diseases including diabetes, tuberculosis, and cancers, and has achieved a consistent and notable record of success and influence in this and other related areas of study.
Furthermore, his work has been published in leading journals in the field, which has resulted in 15 peer-reviewed scientific articles, boasting an impact factor of 69.504, and his work has been cited 233 times by his peers in at least 37 countries. Therefore, this affirms that the scientific community deems him to be a central voice in his areas of scholarly inquiry.
In addition, he has spent years investigating issues related to organic compound identification, design, and synthesis, and he is regarded as an authority in the field. The field has recognized his authority by inviting him to review and evaluate the work of his peers no fewer than 92 times. He serves as an editor for 5 prestigious journals in his field, and in these positions, he plays an even larger role in qualifying the work of his peers. Peer review is considered “the only widely accepted method for research validation,” with publishers relying on the peer review process “to uphold the quality and validity of individual articles and the journals that publish them”. His consistent peer review experience thus serves as further evidence of his authority in the field.
Hence, we agreed and went ahead with preparing his case and ensured that we had every relevant information available to achieve approval without any hurdles. This meant going through his CV, transcripts, certificates, awards, letters of recommendation, publication and citation history, peer review count, etc.
After perusing these documents, our team found substantial evidence to prove that his work has a crucial impact on some of our nation’s and the world’s most pressing issues, including combatting major public health threats such as cancer, diabetes, and tuberculosis, and is indeed of great importance and relevance in the field.
Moreover, we added four letters of recommendation obtained from his fellow experts in the field of medicinal chemistry, discussing our client’s accomplishments further. One of his recommenders opinionated:
“I am writing this letter in support of [client], a highly skilled and competent medicinal chemist whose research is of great importance to the United States. He has quickly risen to the forefront of his field due to his success in utilizing a variety of techniques to design and synthesize drug-like compounds for use in treatments of tuberculosis, cancer, diabetes, and other conditions. This has made him particularly well-suited to contributing significantly to solving some of the most pressing challenges arising in medicinal chemistry.”
Therefore, these repeated successes in his past work demonstrate that our client is a true leader in his area of research and provide a veritable guarantee that he will continue to advance the field as a whole. As such, his current and future research presents an invaluable opportunity for the research community of the United States of America. When the approval came through in January of 2023 only 13 days after the premium processing service upgrade, we could only share in the joy of our client’s success. We appreciate his continued trust in us and we look forward to assisting him further since he has retained us for his I-485 applications as well.